CKD-702 Plus Irinotecan in Gastric Cancer

NCT05750290 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER_GOV

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: CKD-702 in combination with irinotecan

Sponsor

National Cancer Center, Korea